Prostate News Archive
11-Aug-2006
Drug kills prostate tumor cells (UPI)
DURHAM, N.C., Aug. 10 (UPI) -- U.S. scientists have developed an experimental RNA-based drug -- the first of its kind -- that kills prostate cancer cells, without harming normal cells. Generex expands vaccine trials to include prostate cancer (Pharmaceutical Business Review)
Generex Biotechnology has entered into an agreement with the Euroclinic in Athens, Greece to commence clinical trials to evaluate AE37 in patients with prostate cancer. No ?watchful waiting? with prostate (Fort Wayne Journal Gazette)
It was, many physicians would say, the right thing for a man of 53 to do. So Larry Cano had a prostate-specific antigen, or PSA, test. Prostate Cancer Cells Killed by RNA-Based Drug (Senior Journal)
August 10, 2006 - Acting as a genetic Trojan horse, an experimental RNA-based drug -- the first of its kind -- tricks its way into prostate cancer cells and then springs into action to destroy them, while leaving normal cells unharmed. First-Ever RNA Drug Targets Prostate Cancer (MedicineNet.com)
Title: First-Ever RNA Drug Targets Prostate Cancer Category: Health News Created: 8/10/2006 1:57:00 AM Last Editorial Review: 8/10/2006 1:56:49 AM Experimental RNA-based Drug Kills Prostate Cancer Cells Effectively And Safely (Science Daily)
Acting as a genetic Trojan horse, an experimental RNA-based drug -- the first of its kind -- tricks its way into prostate cancer cells and then springs into action to destroy them, while leaving normal cells unarmed. First-Ever RNA Drug Targets Prostate Cancer (HealthDay via Yahoo! News)
WEDNESDAY, Aug. 9 (HealthDay News) -- An experimental gene-based drug is able to "trick" its way into prostate cancer cells and kill them, U.S. researchers report. RNA-Based Drug Kills Prostate-Cancer Cells (RedNova)
Researchers at Duke University recently discovered that using a two-module ribonucleic acid system safely reduces prostate-tumor size two-fold.
Back to Prostate News Archive
